Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Akari Therapeutics PLC (NASDAQ:AKTX) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 148.77K a 247.96K. Questo rappresenta il 1.19% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Akari Therapeutics Corp (XNAS:AKTX) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 115.45K azioni scambiate al giorno, ci vorrebbero 2.15 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
247.96K
Vendite allo scoperto %
1.19%
Giorni di copertura
2.15
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
AKTX | Akari Therapeutics plc ADS | 10/15/2025 | 10/24/2025 | 1.19% | 20,832,958 | 247,961 | 115,446 | 2.15 | |
AKTX | Akari Therapeutics plc ADS | 09/30/2025 | 10/09/2025 | 0.71% | 20,832,958 | 148,771 | 778,848 | 1 | |
AKTX | Akari Therapeutics plc ADS | 09/15/2025 | 09/24/2025 | 0.41% | 20,832,958 | 84,770 | 130,911 | 1 | |
AKTX | Akari Therapeutics plc ADS | 08/29/2025 | 09/10/2025 | 0.12% | 20,832,958 | 24,554 | 50,422 | 1 | |
AKTX | Akari Therapeutics plc ADS | 08/15/2025 | 08/26/2025 | 0.37% | 20,832,958 | 76,916 | 42,220 | 1.82 | |
AKTX | Akari Therapeutics plc ADS | 07/31/2025 | 08/11/2025 | 0.21% | 20,394,597 | 43,232 | 32,665 | 1.32 | |
AKTX | Akari Therapeutics plc ADS | 07/15/2025 | 07/24/2025 | 0.18% | 20,394,597 | 36,702 | 14,987 | 2.45 | |
AKTX | Akari Therapeutics plc ADS | 06/30/2025 | 07/10/2025 | 0.20% | 20,394,597 | 39,900 | 27,419 | 1.46 | |
AKTX | Akari Therapeutics plc ADS | 06/13/2025 | 06/25/2025 | 0.16% | 20,394,597 | 32,143 | 28,117 | 1.14 | |
AKTX | Akari Therapeutics plc ADS | 05/30/2025 | 06/10/2025 | 0.57% | 20,630,679 | 117,901 | 9,252 | 12.74 | |
AKTX | Akari Therapeutics plc ADS | 05/15/2025 | 05/27/2025 | 0.57% | 20,630,679 | 118,286 | 18,333 | 6.45 | |
AKTX | Akari Therapeutics plc ADS | 04/30/2025 | 05/09/2025 | 0.64% | 17,330,800 | 110,565 | 45,670 | 2.42 | |
AKTX | Akari Therapeutics plc ADS | 04/15/2025 | 04/25/2025 | 0.44% | 17,330,800 | 76,994 | 14,652 | 5.25 | |
AKTX | Akari Therapeutics plc ADS | 03/31/2025 | 04/09/2025 | 0.32% | 23,761,637 | 75,637 | 41,914 | 1.8 | |
AKTX | Akari Therapeutics plc ADS | 03/14/2025 | 03/25/2025 | 0.36% | 23,761,637 | 85,606 | 22,637 | 3.78 | |
AKTX | Akari Therapeutics plc ADS | 02/28/2025 | 03/11/2025 | 0.33% | 23,761,637 | 77,335 | 25,988 | 2.98 | |
AKTX | Akari Therapeutics plc ADS | 02/14/2025 | 02/26/2025 | 0.33% | 23,761,637 | 77,707 | 32,895 | 2.36 | |
AKTX | Akari Therapeutics plc ADS | 01/31/2025 | 02/11/2025 | 0.53% | 23,761,637 | 126,747 | 20,615 | 6.15 | |
AKTX | Akari Therapeutics plc ADS | 01/15/2025 | 01/27/2025 | 0.54% | 23,761,637 | 127,361 | 75,840 | 1.68 | |
AKTX | Akari Therapeutics plc ADS | 12/31/2024 | 01/10/2025 | 0.61% | 23,761,637 | 144,166 | 67,126 | 2.15 | |
AKTX | Akari Therapeutics plc ADS | 12/13/2024 | 12/24/2024 | 0.31% | 23,761,637 | 74,099 | 55,463 | 1.34 | |
AKTX | Akari Therapeutics plc ADS | 11/29/2024 | 12/10/2024 | 0.26% | 22,048,235 | 56,941 | 133,915 | 1 | |
AKTX | Akari Therapeutics plc ADS | 11/15/2024 | 11/26/2024 | 0.10% | 22,048,235 | 22,552 | 19,369 | 1.16 | |
AKTX | Akari Therapeutics plc ADS | 10/31/2024 | 11/11/2024 | 0.23% | 9,434,293 | 21,291 | 9,630 | 2.21 | |
AKTX | Akari Therapeutics plc ADS | 10/15/2024 | 10/24/2024 | 0.20% | 9,434,293 | 18,456 | 13,152 | 1.4 | |
AKTX | Akari Therapeutics plc ADS | 09/30/2024 | 10/09/2024 | 0.41% | 9,434,293 | 39,049 | 25,869 | 1.51 | |
AKTX | Akari Therapeutics plc ADS | 09/13/2024 | 09/24/2024 | 0.43% | 9,434,293 | 40,738 | 8,284 | 4.92 | |
AKTX | Akari Therapeutics plc ADS | 08/30/2024 | 09/11/2024 | 0.42% | 9,243,127 | 39,028 | 21,520 | 1.81 | |
AKTX | Akari Therapeutics plc ADS | 08/15/2024 | 08/26/2024 | 0.32% | 9,243,127 | 29,178 | 11,464 | 2.55 | |
AKTX | Akari Therapeutics plc ADS | 07/31/2024 | 08/09/2024 | 0.27% | 9,030,926 | 24,769 | 20,797 | 1.19 | |
AKTX | Akari Therapeutics plc ADS | 07/15/2024 | 07/24/2024 | 0.28% | 9,030,926 | 24,929 | 20,710 | 1.2 | |
AKTX | Akari Therapeutics plc ADS | 06/28/2024 | 07/10/2024 | 0.08% | 9,030,926 | 7,389 | 31,465 | 1 | |
AKTX | Akari Therapeutics plc ADS | 06/14/2024 | 06/26/2024 | 0.17% | 9,030,926 | 15,745 | 39,702 | 1 | |
AKTX | Akari Therapeutics plc ADS | 05/31/2024 | 06/11/2024 | 0.41% | 5,213,373 | 21,616 | 18,616 | 1.16 | |
AKTX | Akari Therapeutics plc ADS | 05/15/2024 | 05/24/2024 | 0.27% | 4,727,822 | 12,631 | 30,901 | 1 | |
AKTX | Akari Therapeutics plc ADS | 04/30/2024 | 05/09/2024 | 0.05% | 4,727,822 | 2,215 | 13,748 | 1 | |
AKTX | Akari Therapeutics plc ADS | 04/15/2024 | 04/24/2024 | 0.01% | 4,727,822 | 575 | 23,886 | 1 | |
AKTX | Akari Therapeutics plc ADS | 03/28/2024 | 04/09/2024 | 0.22% | 4,727,822 | 10,516 | 18,009 | 1 | |
AKTX | Akari Therapeutics plc ADS | 03/15/2024 | 03/26/2024 | 1.04% | 570,287 | 5,949 | 10,839 | 1 | |
AKTX | Akari Therapeutics plc ADS | 02/29/2024 | 03/11/2024 | 1.68% | 570,287 | 9,587 | 4,820 | 1.99 | |
AKTX | Akari Therapeutics plc ADS | 02/15/2024 | 02/27/2024 | 1.52% | 570,287 | 8,652 | 4,872 | 1.78 | |
AKTX | Akari Therapeutics plc ADS | 01/31/2024 | 02/09/2024 | 0.34% | 570,287 | 1,944 | 11,514 | 1 | |
AKTX | Akari Therapeutics plc ADS | 01/12/2024 | 01/24/2024 | 1.00% | 570,287 | 5,717 | 11,309 | 1 | |
AKTX | Akari Therapeutics plc ADS | 12/29/2023 | 01/10/2024 | 0.21% | 570,287 | 1,221 | 9,002 | 1 | |
AKTX | Akari Therapeutics plc ADS | 12/15/2023 | 12/27/2023 | 0.29% | 570,287 | 1,678 | 7,658 | 1 | |
AKTX | Akari Therapeutics plc ADS | 11/30/2023 | 12/11/2023 | 0.59% | 570,287 | 3,388 | 10,289 | 1 | |
AKTX | Akari Therapeutics plc ADS | 11/15/2023 | 11/27/2023 | 1.97% | 570,287 | 11,209 | 6,435 | 1.74 | |
AKTX | Akari Therapeutics plc ADS | 10/31/2023 | 11/09/2023 | 3.06% | 570,287 | 17,467 | 19,612 | 1 |
In cerca di azioni più vendute allo scoperto?